FDA
-
-
-
-
-
-
-
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on SINTX Tech (SINT)
-
-
-
-
-
-
-
SINTX Technologies names Ryan Elmore as president
-
-
-
-
-
-
-
SINTX Technologies receives FDA clearance for foot and ankle implant
-
-
-
-
-
-
-
SINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices
-
-
-
-
-
-
-
SINTX Technologies (SINT) Receives Issuance of U.S. Patent for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial
-
-
-
-
-
-
-
SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants
-
331,903 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

